Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1092977-61-1
2. 2-((3-butoxyphenethyl)amino)-n,n-dimethylacetamide
3. Evenamide [inn]
4. Nw-3509
5. On5s6n53js
6. Mfcd28502433
7. 2-((2-(3-butoxyphenyl)ethyl)amino)-n,n-dimethylacetamide
8. Acetamide, 2-((2-(3-butoxyphenyl)ethyl)amino)-n,n-dimethyl-
9. 2-[(3-butoxyphenethyl)amino]-n,n-dimethylacetamide
10. Unii-on5s6n53js
11. Evenamid
12. Evenamide [who-dd]
13. Schembl3025285
14. Chembl3678076
15. Bdbm161090
16. Dtxsid101032897
17. Sb18910
18. Ac-35786
19. As-48527
20. Hy-17612
21. Sy244487
22. Cs-0014697
23. F50592
24. Q21098995
25. 2-[2-(3-butoxyphenyl)ethylamino]-n,n-dimethylacetamide
26. Us9051240, 2-[2-(3-butoxyphenyl)-ethylamino]-n,n-dimethylacetamide
| Molecular Weight | 278.39 g/mol |
|---|---|
| Molecular Formula | C16H26N2O2 |
| XLogP3 | 2.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 9 |
| Exact Mass | 278.199428076 g/mol |
| Monoisotopic Mass | 278.199428076 g/mol |
| Topological Polar Surface Area | 41.6 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 269 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Evenamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Evenamide, including repackagers and relabelers. The FDA regulates Evenamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Evenamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Evenamide supplier is an individual or a company that provides Evenamide active pharmaceutical ingredient (API) or Evenamide finished formulations upon request. The Evenamide suppliers may include Evenamide API manufacturers, exporters, distributors and traders.
Evenamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Evenamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Evenamide GMP manufacturer or Evenamide GMP API supplier for your needs.
A Evenamide CoA (Certificate of Analysis) is a formal document that attests to Evenamide's compliance with Evenamide specifications and serves as a tool for batch-level quality control.
Evenamide CoA mostly includes findings from lab analyses of a specific batch. For each Evenamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Evenamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Evenamide EP), Evenamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Evenamide USP).
LOOKING FOR A SUPPLIER?
